Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 1,521–1,540 of 17,937 drug recalls

Drug Recall Terminated Historical recordClass I

Acetaminophen Extra Strength Tablets, 500 mg each, 100 count bottles, Packaged By: A-S Medication Solutions, Libertyville, IL 60048. NDC: 50090-5313-2

by A-S Medication Solutions LLC

Reason
Labeling: Label Mix-Up: Some bottles of Acetaminophen Extra Strength 500 mg tablets were incorrectly labeled with the drug facts label for Aspirin 81 mg tablets.
Recall initiated
June 21, 2024
Reported by FDA
August 14, 2024
Distribution
Nationwide within the United States.

View recall →

Drug Recall Terminated Historical recordClass II

Empower Pharmacy, Estradiol Cypionate Injection, 10mg/mL, 5mL Sterile Multiple Dose Vial, For IM or SQ use only, RX only, Compounded by: Empower Pharmacy 7601 N Sam Houston Pkwy W Ste 100, Houston, TX 77064

by EMPOWER CLINIC SERVICES LLC

Reason
Lack of Assurance of Sterility
Recall initiated
August 2, 2024
Reported by FDA
August 14, 2024
Distribution
Nationwide within the United States

View recall →

Drug Recall Completed Historical recordClass III

Methotrexate Tablets, USP, 2.5mg, 100-count Bottle, RX Only, Distributed By: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC# 69238-1423-1

by Amneal Pharmaceuticals, LLC

Reason
Presence of Foreign Tablets: Potential presence of Fludrocortisone Acetate Tablet USP 0.1 mg within the Methotrexate 2.5 mg 100-count Bottle.
Recall initiated
August 1, 2024
Reported by FDA
August 14, 2024
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass III

PEG-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate, and Ascorbic Acid for Oral Solution 100g/7.5 g /2.691 g/1.015 g/ 5.9 g / 4.7 g, 3 pouches/carton, Rx only, Distributed by: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC# 0093-3560-26.

by Novel Laboratories, Inc. d.b.a Lupin Somerset

Reason
Defective container: potential for non-sealed pouches which can lead to product leakage.
Recall initiated
July 2, 2024
Reported by FDA
August 14, 2024
Distribution
Nationwide in the US.

View recall →

Drug Recall Terminated Historical recordClass III

Acetaminophen, USP 500mg, Pain Reliever/Fever Reducer, Extra Strength, Rapid Release Gelcaps, packaged in a 225-count HDPE bottle, further packaged in a carton, Distributed by Walgreen Co., 200 Wilmot Rd, Deerfield, IL 60015, Made in India

by Granules Consumer Health Inc.

Reason
Label mix-up: Carton incorrectly labeled.
Recall initiated
July 18, 2024
Reported by FDA
August 14, 2024
Distribution
Recalled lot was distributed to one distributor in IL who may have further distributed the product to the retail level.

View recall →

Drug Recall Ongoing Historical recordClass I

Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.

by MAIN PRODUCTS INC

Reason
Marketed without Approved NDA/ANDA. FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.
Recall initiated
July 18, 2024
Reported by FDA
August 14, 2024
Distribution
Nationwide within the U.S

View recall →

Drug Recall Ongoing Historical recordClass III

Sevelamer Carbonate for Oral Suspension 0.8g packets, packaged in 90 packets per container, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India NDC 43598-478-90

by Dr. Reddy's Laboratories, Inc.

Reason
Labeling: Incorrect or Missing Lot and/or Exp Date. Missing lot number and expiration dates on packets
Recall initiated
June 26, 2024
Reported by FDA
August 14, 2024
Distribution
Nationwide within the United States

View recall →

Drug Recall Ongoing Historical recordClass II

Progesterone Injection, USP, 500 mg per 10 mL (50mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E Windsor, NJ 08520, NDC 55150-306-10.

by Eugia US LLC

Reason
Presence of Particulate Matter: Complaint received of a glass particle in the vial.
Recall initiated
July 26, 2024
Reported by FDA
August 7, 2024
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass II

Ciprofloxacin ophthalmic solution USP, 0.3% as base, package in bottles: a) 10 mL (NDC 69315-308-10), b) 2.5 mL (NDC 69315-308-02), Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India.

by FDC Limited

Reason
Defective container: unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.
Recall initiated
July 23, 2024
Reported by FDA
August 7, 2024
Distribution
U.S. A. Nationwide

View recall →

Drug Recall Terminated Historical recordClass I

Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.125mg, 60 tablets per carton (10 blister cards containing 6 tablets each), Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC# 49884-306-02.

by Endo Pharmaceuticals, Inc.

Reason
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25 mg. The blister strips inside the product carton reflect the correct strength of 0.25 mg.
Recall initiated
July 10, 2024
Reported by FDA
August 7, 2024
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Ongoing Historical recordClass II

Glenmark, Azelaic Acid Gel, 15 %, 50 grams, Rx only, Manufactured by: Glenmark Pharmaceuticals Limited, Colvale-Bardez, Goa, 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-626-52.

by Glenmark Pharmaceuticals Inc., USA

Reason
CGMP Deviations
Recall initiated
July 22, 2024
Reported by FDA
August 7, 2024
Distribution
U.S. Nationwide

View recall →

Drug Recall Ongoing Historical recordClass I

Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.

by SoloVital

Reason
Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.
Recall initiated
July 12, 2024
Reported by FDA
August 7, 2024
Distribution
Nationwide within the United States

View recall →

Drug Recall Ongoing Historical recordClass I

Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq K, a).100-count bottle ( NDC 68001-396-00), b) 500-count bottle (NDC 68001-396-03), Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot No. 2, Phase-2, Pharma Zone SEZ, Pithampur, Distributed by: Dhar, Madhya Pradesh 454 775, India. Distributed for: BluePoint Laboratories.

by Amerisource Health Services LLC

Reason
Failed Dissolution Specifications
Recall initiated
June 25, 2024
Reported by FDA
August 7, 2024
Distribution
US Nationwide.

View recall →

Drug Recall Terminated Historical recordClass III

Complete 30C/200C Homeopathic Kit, Contains: One hundred 1/2 dram vials of homeopathic medicines, Washington Homeopathic Products, Inc., Berkley Springs, WV 25411, UPC 7 40640 64300 6.

by Washington Homeopathic Products, Inc.

Reason
Labeling: Label Mix-up: Some bottles of Ferrum Phosphoricum 200C were incorrectly labeled as Ferrum Metallicum 200C.
Recall initiated
May 31, 2024
Reported by FDA
July 31, 2024
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5mg, packaged in a) 90-count bottles (NDC 68382-034-16) and b)1000-count bottles (NDC 68382-034-10), Rx only, Mfg. by: Zydus Lifesciences Ltd. Ahmedabad, India; Dist. by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534

by Zydus Pharmaceuticals (USA) Inc

Reason
Failed Dissolution Specifications: Out-of-specification results observed for dissolution testing at the 8-hour and 12-hour pull intervals.
Recall initiated
June 21, 2024
Reported by FDA
July 31, 2024
Distribution
Nationwide within the United States

View recall →

Drug Recall Ongoing Historical recordClass III

Hemp Bombs CBD Pain Freeze (menthol 4%), 1000mg, 4 oz bottles, Distributed by: Global Widget 8419 Sunstate St, Tampa FL 33634; UPC Code: 8-40078-56612-7

by GLOBAL WIDGET LLC

Reason
Subpotent drug: The potency of the active (menthol) was less than the label claim of 4%.
Recall initiated
June 25, 2024
Reported by FDA
July 31, 2024
Distribution
Nationwide within the United States

View recall →

Drug Recall Ongoing Historical recordClass III

Hemp Bombs CBD Pain Freeze (menthol 4%), 400mg, 4 oz bottles, Distributed by: Global Widget 8419 Sunstate St, Tampa FL 33634; UPC code: 8-40078-56497-0

by GLOBAL WIDGET LLC

Reason
Subpotent drug: The potency of the active (menthol) was less than the label claim of 4%.
Recall initiated
June 25, 2024
Reported by FDA
July 31, 2024
Distribution
Nationwide within the United States

View recall →

Drug Recall Ongoing Historical recordClass III

Nature's Script CBD Cryotherapy Pain Relief Roll on (menthol 4%) 200mg, 1 oz bottles, Distributed by: Global Widget 8419 Sunstate St, Tampa FL 33634, UPC code: 8-40078-56731-5

by GLOBAL WIDGET LLC

Reason
Subpotent drug: The potency of the active (menthol) was less than the label claim of 4%.
Recall initiated
June 25, 2024
Reported by FDA
July 31, 2024
Distribution
Nationwide within the United States

View recall →

Drug Recall Ongoing Historical recordClass III

Hemp Bombs CBD Pain Freeze (menthol 4%), 100mg, 1 oz bottles, Distributed by: Global Widget 8419 Sunstate St, Tampa FL 33634, NDC 73423-003-01; UPC Code: 8-40078-56493-2

by GLOBAL WIDGET LLC

Reason
Subpotent drug: The potency of the active (menthol) was less than the label claim of 4%.
Recall initiated
June 25, 2024
Reported by FDA
July 31, 2024
Distribution
Nationwide within the United States

View recall →

Drug Recall Ongoing Historical recordClass II

Pravastatin Sodium Tablets, USP 80mg, packaged in a) 90-count bottle, NDC 68462-198-90; b) 500-count bottle, NDC 68462-198-05, Rx only, Manufactured by: Glenmark Pharmaceuticals Limited Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430,

by Glenmark Pharmaceuticals Inc., USA

Reason
Failed Dissolution Specifications: results below specifications
Recall initiated
June 28, 2024
Reported by FDA
July 24, 2024
Distribution
USA Nationwide

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.